SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-11-014482
Filing Date
2011-02-16
Accepted
2011-02-16 07:17:30
Documents
8
Period of Report
2011-02-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K b85002e8vk.htm 8-K 40579
2 EX-2.1 b85002exv2w1.htm EX-2.1 668896
3 EX-10.1 b85002exv10w1.htm EX-10.1 285835
4 EX-99.1 b85002exv99w1.htm EX-99.1 400554
5 EX-99.2 b85002exv99w2.htm EX-99.2 26415
6 GRAPHIC b85002b8500200.gif GRAPHIC 2616
7 GRAPHIC b85002b8500201.gif GRAPHIC 7816
8 GRAPHIC b85002b8500200a.gif GRAPHIC 5210
  Complete submission text file 0000950123-11-014482.txt   1445886
Mailing Address 500 KENDALL STREET CAMBRIDGE MA 02142
Business Address 500 KENDALL STREET CAMBRIDGE MA 02142 6172527500
GENZYME CORP (Filer) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14680 | Film No.: 11616007
SIC: 2836 Biological Products, (No Diagnostic Substances)